Announced a new $110 million funding round on Monday medical home Reflects the continued expansion of home hospital-level care.
The latest infusion services are provided by medical technology company Baxter International, mobile healthcare leader Global Medical Response and Cardinal Health, which distributes medical supplies, including home care. They join Mayo Clinic and Kaiser Permanente as strategic investors and will have representation on Medical Home’s board of directors.
Kaiser and Mayo also provided additional funding They invested $100 million exist medical home Expand its business and make its care model available to more hospitals in May 2021. The Boston-based company provides technology and platforms for clinicians to collaborate remotely with medical staff in patients’ homes to treat high-risk conditions ranging from Covid-19 to heart failure and cancer.
This pattern has gained traction over the past two decades, but the pandemic has accelerated growth as Covid-19 has made hospitals and clinics dangerous places for the spread of infectious diseases. The pandemic has also tested the capacity of hospitals across the country.A generationInvestors are responding to healthcare demand and consumer demand, which exceeds the number of hospital beds, to expand what types of medical services can be offered from the comfort of home.
Extensive Federal Regulatory Changes During the pandemic, flexibility has been created for providing a higher level of care at home, with details on how to do it safely. Medically Home’s own model features a 24/7 medical command center staffed with nurses and doctors who work with teams of nurses, paramedics and technicians on-site.Many patients prefer to be treated at home, the hospital home care model has been Shows increased clinical benefit compared to hospitalization. This includes a reduction in readmissions and a reduction in acquired infections.
In response to the changing consumer and healthcare environment, many providers and some payers are now taking a deeper look at what kind of hospital-grade care can be provided at home. Some hospitals have created their own programs, while companies such as Current Health offer platforms to support home hospital programs.
To date, more than 7,000 patients have been treated using Medically Home’s platform, which says utilization is growing rapidly, according to the company.
“The addition of these strategic national partners strongly enhances our logistical capabilities our health system providers need to safely and securely care for patients at home,” said Rami Karjian, CEO of Medically Home, in a press release about the latest investment. . “With Medically Home, the accelerated dispersal of high-sensitivity care from hospitals and other institutional settings to a growing number of patients’ homes validates the importance of a healthcare partner ecosystem that represents patients alongside the clinicians who care for them. Work country.”
Funding aside, each strategic partner is part of a puzzle that seeks to support seamless high-sensitivity care in the home. For example, Medicly Home’s partnership with GMR has enabled it to add more clinicians in the field, while its partnership with Baxter has given it access to a wider range of medical and digital health solutions.
“Baxter’s strategic investment in Medically Home will help advance our vision to transform healthcare by accelerating access to hospital-grade care at home,” Giuseppe Accogli, Baxter’s executive vice president and chief operating officer, said in a press release. “Covid-19 The -19 pandemic has enhanced the value of helping clinicians provide the best possible care for their patients at home, and we are excited to help Medically Home expand its unique model of care while further driving innovation in digital health and monitoring technologies and solutions.”
Photo: SDI Productions, Getty Images
